Value chain stagesFinished Product

Products 81 to 90 of 171

High Fiber Wheat by Catalyxt
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 608,825,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: CLXT (NASDAQ)
Value chain stage: Finished Product
High Oleic Soybean by Catalyxt
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 608,825,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: CLXT (NASDAQ)
Value chain stage: Finished Product
Houseplant with Rabbit DNA by University of Washington
Biotech components: Animal + Plant
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (3 years ago)
Date last modified: 2019/04/01 10:01 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: N/A
Market status: Under Development
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Humanized Pig Organs by Synthetic Genomics + United Therapeutics’ Lung Biotechnology Inc
Biotech components: Animal
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/09/28 15:05 (3 years ago)
Known funding amount: 40,000,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Hydrogen Sulfide Sourced Fuels by Ginkgo Bioworks
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/02 11:54 (3 years ago)
Known funding amount: 6,438,793 USD
Funding types: Government
Industry: Energy
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Molecule
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (3 years ago)
Date last modified: 2019/04/12 09:36 (3 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: Under Development + More information needed
Organization type(s): N/A
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Impossible Burger by Impossible Foods
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 189,000,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Innate Potato by JR Simplot Company
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: Canada + Australia + Japan + China + South Korea + Malaysia + Mexico + New Zealand + Taiwan + USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/09/12 16:42 (3 years ago)
Known funding amount: 5,800,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Enzyme
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 200,000,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Finished Product
Insulin-producing bacteria by Venter Institute
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/01 09:50 (3 years ago)
Known funding amount: 50,000 USD
Funding types: Foundation
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product